216 related articles for article (PubMed ID: 33527464)
1. Diabetes predicts severity of COVID-19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C-reactive protein.
Koh H; Moh AMC; Yeoh E; Lin Y; Low SKM; Ooi ST; Tan SK; Lin JHX; Hoong CWS
J Med Virol; 2021 May; 93(5):3023-3032. PubMed ID: 33527464
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.
Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD
Diabetes Metab Res Rev; 2021 Mar; 37(3):e3388. PubMed ID: 32683744
[TBL] [Abstract][Full Text] [Related]
3. Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study.
Xu AY; Wang SH; Duong TQ
BMJ Open Diabetes Res Care; 2023 Jun; 11(3):. PubMed ID: 37295808
[TBL] [Abstract][Full Text] [Related]
4. CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study.
Lorè NI; De Lorenzo R; Rancoita PMV; Cugnata F; Agresti A; Benedetti F; Bianchi ME; Bonini C; Capobianco A; Conte C; Corti A; Furlan R; Mantegani P; Maugeri N; Sciorati C; Saliu F; Silvestri L; Tresoldi C; ; Ciceri F; Rovere-Querini P; Di Serio C; Cirillo DM; Manfredi AA
Mol Med; 2021 Oct; 27(1):129. PubMed ID: 34663207
[TBL] [Abstract][Full Text] [Related]
5. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Leucocyte to High-Density Lipoprotein-Cholesterol Ratios in COVID-19 Patients and the Diabetes Subgroup.
Wang Y; Zhang J; Li H; Kong W; Zheng J; Li Y; Wei Q; Li Q; Yang L; Xu Y; Li L; Wang H; Sun H; Xia W; Liu G; Zhong X; Qiu K; Wang H; Liu H; Song X; Xiong S; Liu Y; Cui Z; Chen L; Zeng T
Front Endocrinol (Lausanne); 2021; 12():727419. PubMed ID: 34589058
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019.
Zhang W; Li C; Xu Y; He B; Hu M; Cao G; Li L; Wu S; Wang X; Zhang C; Zhao J; Xie J; Xu Z; Li Q; Wang G
Mediators Inflamm; 2021; 2021():8812304. PubMed ID: 33814982
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.
Alguwaihes AM; Al-Sofiani ME; Megdad M; Albader SS; Alsari MH; Alelayan A; Alzahrani SH; Sabico S; Al-Daghri NM; Jammah AA
Cardiovasc Diabetol; 2020 Dec; 19(1):205. PubMed ID: 33278893
[TBL] [Abstract][Full Text] [Related]
9. The value of clinical parameters in predicting the severity of COVID-19.
Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
[TBL] [Abstract][Full Text] [Related]
10. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.
Ramesh J; Reddy SLS; Rajesh M; Varghese J
Diabetes Metab Syndr; 2021; 15(3):739-745. PubMed ID: 33819728
[TBL] [Abstract][Full Text] [Related]
12. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
13. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19.
Xue G; Gan X; Wu Z; Xie D; Xiong Y; Hua L; Zhou B; Zhou N; Xiang J; Li J
Int Immunopharmacol; 2020 Dec; 89(Pt A):107065. PubMed ID: 33045571
[TBL] [Abstract][Full Text] [Related]
14. Chronic dysglycemia and risk of SARS-CoV-2 associated respiratory failure in hospitalized patients.
Rysz S; Jonsson Fagerlund M; Rimes-Stigare C; Larsson E; Campoccia Jalde F; Mårtensson J
Acta Anaesthesiol Scand; 2022 Jan; 66(1):48-55. PubMed ID: 34582033
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infection.
Smith M; Lara OD; O'Cearbhaill R; Knisely A; McEachron J; Gabor L; Carr C; Blank S; Prasad-Hayes M; Frey M; Jee J; Fehniger J; Wang Y; Lee YC; Isani S; Wright JD; Pothuri B
Gynecol Oncol; 2020 Dec; 159(3):618-622. PubMed ID: 33019984
[TBL] [Abstract][Full Text] [Related]
16. Implications of an HbA1c-based Diabetes Screening on Prevalence and Effect of Dysglycemia in Patients With COVID-19.
Van Baal L; Reinold J; Benson S; Diehl A; Witzke O; Fuehrer D; Tan S
J Clin Endocrinol Metab; 2023 Feb; 108(3):697-705. PubMed ID: 36221157
[TBL] [Abstract][Full Text] [Related]
17. The outcomes of patients with diabetes mellitus in The Philippine CORONA Study.
Espiritu AI; Chiu HHC; Sy MCC; Anlacan VMM; ; Jamora RDG
Sci Rep; 2021 Dec; 11(1):24436. PubMed ID: 34952903
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea.
Kim MK; Jeon JH; Kim SW; Moon JS; Cho NH; Han E; You JH; Lee JY; Hyun M; Park JS; Kwon YS; Choi YK; Kwon KT; Lee SY; Jeon EJ; Kim JW; Hong HL; Kwon HH; Jung CY; Lee YY; Ha E; Chung SM; Hur J; Ahn JH; Kim NY; Kim SW; Chang HH; Lee YH; Lee J; Park KG; Kim HA; Lee JH
Diabetes Metab J; 2020 Aug; 44(4):602-613. PubMed ID: 32794386
[TBL] [Abstract][Full Text] [Related]
19. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
[TBL] [Abstract][Full Text] [Related]
20. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
[No Abstract] [Full Text] [Related]
[Next] [New Search]
